PDCD1 and colorectal cancer: Furthermore, fluorescence staining of 25 colorectal cancer samples treated with PD-1 immunotherapy exhibited a significant abundance of infiltrating CD8+ T cells in PBRM1-deficient tissues compared to the PBRM1 wild-type group.